Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board
13/04/2026 16:16
April 13 (Reuters) - Duality Biotherapeutics 9606.HK: APPROVED PROPOSED RMB SHARE ISSUE ON SCI-TECH BOARD PROPOSES TO ISSUE NOT MORE THAN 15.8 MILLION RMB SHARES PROCEEDS RAISED FROM RMB SHARE ISSUE WILL BE USED FOR INNOVATIVE DRUG RESEARCH, OTHERS Further company coverage: 9606.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Duality Biotherapeutics
See all newsDuality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up
Brief: Duality Biotherapeutics Says Global Research And Development Collaboration And License Agreement With Genentech
Brief: Duality Biotherapeutics Obtains Acceptance From Shanghai Securities Regulatory Bureau For Counselling On Proposed RMB Share Listing
Brief: Duality Biotherapeutics Announces Share Repurchase Plan Of Up To $40 Million
Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board